Shots:
Merck Animal Health to acquire Vence from its founders and shareholders & the transaction is expected to be completed in Q3’22
Vence provides virtual fencing technology for rotational grazing and livestock management. The technology also allows the cattle producers and ranchers to manage natural resources more effectively
The acquisition will broaden Merck Animal Health’s portfolio of veterinary pharmaceuticals, vaccines, and animal intelligence solutions to advance animal health and well-being along with customers’ outcomes. Additionally, the technology is currently available in the US and parts of Australia
Ref: Businesswire | Image: Merck Animal Health
